Boulieu R, Bory C, Baltassat P, Divry P
Clin Chim Acta. 1984 Sep 15;142(1):83-9. doi: 10.1016/0009-8981(84)90103-7.
In the present paper, we report the biochemical features of six cases of xanthinuria. For these studies, the concentrations of hypoxanthine and xanthine have been measured in urine, plasma and also erythrocyte samples by a rapid, sensitive high performance liquid chromatographic (HPLC) method. The analyses of plasma and erythrocyte samples require a very sensitive method relative to physiological concentrations and rigorous sampling conditions in order to achieve accurate results. In the cases reported in the literature, total oxypurine levels (hypoxanthine + xanthine) have been generally measured in plasma and urine by an enzymatic spectrophotometric method. In our studies, using HPLC, we found that xanthine is the major oxypurine compound in plasma and urine samples from patients with xanthinuria. In erythrocytes, a biological sample which has not been analysed up to now, we found that xanthine is present at high concentrations whereas it is not detectable in erythrocytes from healthy subjects.
在本论文中,我们报告了6例黄嘌呤尿症患者的生化特征。对于这些研究,采用快速、灵敏的高效液相色谱(HPLC)法测定了尿液、血浆以及红细胞样本中次黄嘌呤和黄嘌呤的浓度。相对于生理浓度和严格的采样条件而言,血浆和红细胞样本的分析需要一种非常灵敏的方法才能获得准确的结果。在文献报道的病例中,总氧嘌呤水平(次黄嘌呤+黄嘌呤)通常采用酶分光光度法在血浆和尿液中进行测定。在我们的研究中,通过HPLC发现,黄嘌呤是黄嘌呤尿症患者血浆和尿液样本中的主要氧嘌呤化合物。在红细胞(一种至今尚未进行分析的生物样本)中,我们发现黄嘌呤以高浓度存在,而在健康受试者的红细胞中则检测不到。